Profiling the dysregulated immune response in sepsis: overcoming challenges to achieve the goal of precision medicine-Reference-Cited by-同舟云学术

Profiling the dysregulated immune response in sepsis: overcoming challenges to achieve the goal of precision medicine

Published:2023-12 Issue: Volume: Page:
ISSN:2213-2600
Container-title:The Lancet Respiratory Medicine
language:en
Short-container-title:The Lancet Respiratory Medicine

Author:

Cajander Sara,Kox Matthijs,Scicluna Brendon P,Weigand Markus A,Mora Raquel Almansa,Flohé Stefanie B,Martin-Loeches Ignacio,Lachmann Gunnar,Girardis Massimo,Garcia-Salido Alberto,Brunkhorst Frank M,Bauer Michael,Torres Antoni,Cossarizza Andrea,Monneret Guillaume,Cavaillon Jean-Marc,Shankar-Hari Manu,Giamarellos-Bourboulis Evangelos J,Winkler Martin Sebastian,Skirecki Tomasz,Osuchowski Marcin,Rubio Ignacio,Bermejo-Martin Jesus F,Schefold Joerg C,Venet Fabienne

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine

Reference215 articles.

1. The Surviving Sepsis Campaign: results of an international guideline-based performance improvement program targeting severe sepsis;Levy;Intensive Care Med,2010

2. Global, regional, and national sepsis incidence and mortality, 1990–2017: analysis for the Global Burden of Disease Study;Rudd;Lancet,2020

3. Hydrocortisone in severe community-acquired pneumonia;Dequin;N Engl J Med,2023

4. The last 100 years of sepsis;Vincent;Am J Respir Crit Care Med,2006

5. Efficacy and safety of recombinant human activated protein C for severe sepsis;Bernard;N Engl J Med,2001

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Using weight loss to predict outcome and define a humane endpoint in preclinical sepsis studies;Scientific Reports;2024-09-10

2. Understanding, assessing and treating immune, endothelial and haemostasis dysfunctions in bacterial sepsis;Intensive Care Medicine;2024-09-02

3. Determining potential immunomodulatory drug efficacy in sepsis using ELISpot;2024-07-16

4. Integrated clustering of multiple immune marker trajectories reveals different immunotypes in severely injured patients;Critical Care;2024-07-15

5. Enhancing sepsis biomarker development: key considerations from public and private perspectives;Critical Care;2024-07-13